Bibliography: library/10665-117378
The reference for library/10665-117378 (who-iris) and any references extracted from it. library · All references.
Export these 17 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD
✍ + Add reference (standalone node)
17 shown
-
Ahmed, A.A.; Latoundji, S. (2007). [Pilot study of antiretroviral therapy in Djibouti].
10665-117378· catalogue · link · repository record · source:catalogue/records/10665-117378.dc.json· held:library/10665-117378
export: BibTeX · RIS · CSL-JSON · DC XML -
Rapport sur l'épidémie mondiale de SIDA. 4ème rapport mondial. Programme com-mun des Nations Unies sur le VIH/SIDA (ONUSIDA). Genève, 2004.
· extracted · source:references/10665-117378.page-011.1.jsonRapport sur l'épidémie mondiale de SIDA. 4ème rapport mondial. Programme com-mun des Nations Unies sur le VIH/SIDA (ONUSIDA). Genève, 2004.
- Issued
- 2004
- Type
- document
- As printed
- Rapport sur l'épidémie mondiale de SIDA. 4ème rapport mondial. Programme com-mun des Nations Unies sur le VIH/SIDA (ONUSIDA). Genève, 2004.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.1 - provenance: extracted
- read from
references/10665-117378.page-011.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
The 3 by 5 initiative (http://www.who.int/3by5/en, consulté le 17 avril 2007).
· extracted · link · source:references/10665-117378.page-011.2.jsonThe 3 by 5 initiative (http://www.who.int/3by5/en, consulté le 17 avril 2007).
- Type
- document
- Accessed
- 17 avril 2007
- As printed
- The 3 by 5 initiative (http://www.who.int/3by5/en, consulté le 17 avril 2007).
Sources
- www.who.int/3by5/en (canonical)
In the knowledge graph
- IRI
references/10665-117378.page-011.2 - provenance: extracted
- read from
references/10665-117378.page-011.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Laurent C et al. The Senegalese govern-ment's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS, 2002, 16:1363-70.
· extracted · source:references/10665-117378.page-011.3.jsonLaurent C et al. The Senegalese govern-ment's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS, 2002, 16:1363-70.
- Issued
- 2002
- Type
- article-journal
- As printed
- Laurent C et al. The Senegalese govern-ment's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS, 2002, 16:1363-70.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.3 - provenance: extracted
- read from
references/10665-117378.page-011.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Zekeng P. Contribution au suivi biologi-que des malades de l'Initiative béninoise d'accès aux ARV [Thèse de médecine]. Cotonou, 2003, N° 1075 : 128.
· extracted · source:references/10665-117378.page-011.4.jsonZekeng P. Contribution au suivi biologi-que des malades de l'Initiative béninoise d'accès aux ARV [Thèse de médecine]. Cotonou, 2003, N° 1075 : 128.
- Issued
- 2003
- Type
- document
- As printed
- Zekeng P. Contribution au suivi biologi-que des malades de l'Initiative béninoise d'accès aux ARV [Thèse de médecine]. Cotonou, 2003, N° 1075 : 128.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.4 - provenance: extracted
- read from
references/10665-117378.page-011.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Ganiou R. Étude de suivi des PVVIH sous traitement antirétroviral dans le cadre de l'Initiative béninoise d'accès aux ARV [Thèse de médecine]. Cotonou, 2003, N° 1066 : 90.
· extracted · source:references/10665-117378.page-011.5.jsonGaniou R. Étude de suivi des PVVIH sous traitement antirétroviral dans le cadre de l'Initiative béninoise d'accès aux ARV [Thèse de médecine]. Cotonou, 2003, N° 1066 : 90.
- Issued
- 2003
- Type
- document
- As printed
- Ganiou R. Étude de suivi des PVVIH sous traitement antirétroviral dans le cadre de l'Initiative béninoise d'accès aux ARV [Thèse de médecine]. Cotonou, 2003, N° 1066 : 90.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.5 - provenance: extracted
- read from
references/10665-117378.page-011.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Ahmed A. Les infections opportunistes au cours de l'infection VIHISIDA à Djibouti [Thèse de médecine]. Cotonou, 1998, N° 753 : 103.
· extracted · source:references/10665-117378.page-011.6.jsonAhmed A. Les infections opportunistes au cours de l'infection VIHISIDA à Djibouti [Thèse de médecine]. Cotonou, 1998, N° 753 : 103.
- Issued
- 1998
- Type
- document
- As printed
- Ahmed A. Les infections opportunistes au cours de l'infection VIHISIDA à Djibouti [Thèse de médecine]. Cotonou, 1998, N° 753 : 103.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.6 - provenance: extracted
- read from
references/10665-117378.page-011.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Okome-Nkoumou M, Mbounja-Loclo ME, Kombila M. Panorama des affections op-portunistes au cours de l'infection par le VIH à Libreville, Gabon. Cahier d'études et de recherches francophones/Santé, 2000, 10(5):329-37.
· extracted · source:references/10665-117378.page-011.7.jsonOkome-Nkoumou M, Mbounja-Loclo ME, Kombila M. Panorama des affections op-portunistes au cours de l'infection par le VIH à Libreville, Gabon. Cahier d'études et de recherches francophones/Santé, 2000, 10(5):329-37.
- Issued
- 2000
- Type
- article-journal
- As printed
- Okome-Nkoumou M, Mbounja-Loclo ME, Kombila M. Panorama des affections op-portunistes au cours de l'infection par le VIH à Libreville, Gabon. Cahier d'études et de recherches francophones/Santé, 2000, 10(5):329-37.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.7 - provenance: extracted
- read from
references/10665-117378.page-011.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Vigan J. Affections opportunistes et rap-port avec le taux de CD4 [Thèse de mé-decine]. Cotonou, 2002, N° 1019 : 124.
· extracted · source:references/10665-117378.page-011.8.jsonVigan J. Affections opportunistes et rap-port avec le taux de CD4 [Thèse de mé-decine]. Cotonou, 2002, N° 1019 : 124.
- Issued
- 2002
- Type
- document
- As printed
- Vigan J. Affections opportunistes et rap-port avec le taux de CD4 [Thèse de mé-decine]. Cotonou, 2002, N° 1019 : 124.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.8 - provenance: extracted
- read from
references/10665-117378.page-011.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Bekker LG et al. Antiretroviral therapy in a community clinic - early lessons from a pi-lot project. South African medical journal, 2003, 93(6):458-62.
· extracted · source:references/10665-117378.page-011.9.jsonBekker LG et al. Antiretroviral therapy in a community clinic - early lessons from a pi-lot project. South African medical journal, 2003, 93(6):458-62.
- Issued
- 2003
- Type
- article-journal
- As printed
- Bekker LG et al. Antiretroviral therapy in a community clinic - early lessons from a pi-lot project. South African medical journal, 2003, 93(6):458-62.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.9 - provenance: extracted
- read from
references/10665-117378.page-011.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Hellinger J et al. A pilot study of saqui-navir-SGC (SQV) and lopinavirritonavir (LPVIR) twice daily in protease inhibitor (PI) naive HIV+ individuals: protease inhi-bitor concentrations and week 24 results. Paper presented at the 2% IAS Conferen-ce on HIV Pathogenesis and Treatment, Paris, 13-17 July, 2003.
· extracted · source:references/10665-117378.page-011.10.jsonHellinger J et al. A pilot study of saqui-navir-SGC (SQV) and lopinavirritonavir (LPVIR) twice daily in protease inhibitor (PI) naive HIV+ individuals: protease inhi-bitor concentrations and week 24 results. Paper presented at the 2% IAS Conferen-ce on HIV Pathogenesis and Treatment, Paris, 13-17 July, 2003.
- Issued
- 2003
- Type
- document
- As printed
- Hellinger J et al. A pilot study of saqui-navir-SGC (SQV) and lopinavirritonavir (LPVIR) twice daily in protease inhibitor (PI) naive HIV+ individuals: protease inhi-bitor concentrations and week 24 results. Paper presented at the 2% IAS Conferen-ce on HIV Pathogenesis and Treatment, Paris, 13-17 July, 2003.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.10 - provenance: extracted
- read from
references/10665-117378.page-011.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Negredo E et al. Virological, immunologi-cal, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immuno-deficiency virus infection and longlasting viral suppression. Clinical infectious di-seases, 2002, 34:504—10.
· extracted · source:references/10665-117378.page-011.11.jsonNegredo E et al. Virological, immunologi-cal, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immuno-deficiency virus infection and longlasting viral suppression. Clinical infectious di-seases, 2002, 34:504—10.
- Issued
- 2002
- Type
- article-journal
- As printed
- Negredo E et al. Virological, immunologi-cal, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immuno-deficiency virus infection and longlasting viral suppression. Clinical infectious di-seases, 2002, 34:504—10.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.11 - provenance: extracted
- read from
references/10665-117378.page-011.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Phillips AN et al. For the Swiss HIV Cohort Study, The Frankfurt HIC Clinic Study and the EuroSIDA, Study Group. Journal of the American Medical Association, 2001, 286:2560-7.
· extracted · source:references/10665-117378.page-011.12.jsonPhillips AN et al. For the Swiss HIV Cohort Study, The Frankfurt HIC Clinic Study and the EuroSIDA, Study Group. Journal of the American Medical Association, 2001, 286:2560-7.
- Issued
- 2001
- Type
- article-journal
- As printed
- Phillips AN et al. For the Swiss HIV Cohort Study, The Frankfurt HIC Clinic Study and the EuroSIDA, Study Group. Journal of the American Medical Association, 2001, 286:2560-7.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.12 - provenance: extracted
- read from
references/10665-117378.page-011.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Hoggs RS et al. Rates of diseases pro-gression by baseline CD4 cell count and viral load after initiating triple-drug the-rapy. Journal of the American Medical Association, 2001, 286:2568-77.
· extracted · source:references/10665-117378.page-011.13.jsonHoggs RS et al. Rates of diseases pro-gression by baseline CD4 cell count and viral load after initiating triple-drug the-rapy. Journal of the American Medical Association, 2001, 286:2568-77.
- Issued
- 2001
- Type
- article-journal
- As printed
- Hoggs RS et al. Rates of diseases pro-gression by baseline CD4 cell count and viral load after initiating triple-drug the-rapy. Journal of the American Medical Association, 2001, 286:2568-77.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.13 - provenance: extracted
- read from
references/10665-117378.page-011.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretro-viral therapy. A/DS, 2001, 15:2251-7. Yes V et ol he EU Al Aa ill ioliue clou ll Ga aol all Eastern Mediterranean Health Journal, Vol. 13, No. 6, 2007
· extracted · source:references/10665-117378.page-011.14.jsonSterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretro-viral therapy. A/DS, 2001, 15:2251-7. Yes V et ol he EU Al Aa ill ioliue clou ll Ga aol all Eastern Mediterranean Health Journal, Vol. 13, No. 6, 2007
- Issued
- 2001
- Type
- article-journal
- As printed
- Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretro-viral therapy. A/DS, 2001, 15:2251-7. Yes V et ol he EU Al Aa ill ioliue clou ll Ga aol all Eastern Mediterranean Health Journal, Vol. 13, No. 6, 2007
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.14 - provenance: extracted
- read from
references/10665-117378.page-011.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
Chêne G et al. Change in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. A/IDS, 1998, 12(17):2313-20. Badri M, Wood R. Usefulness of total lym-phocyte count in moritoring highly active antiretroviral therapy in resource-limited settings. A/IDS, 2003, 17:541-5. Jacobson MA et al. Absolute or total lym-phocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretro-viral therapy. A/IDS, 2003, 17(6):917-9. Lorenzi P. Impact of drug resistance mu-tations on virologic response to salvage therapy. AIDS, 1999, 13:17-21. Piketty C et al. Phenotypic resistance to protease inhibitors in patients who HAART predicts the outcome at weeks
· extracted · source:references/10665-117378.page-011.19.jsonChêne G et al. Change in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. A/IDS, 1998, 12(17):2313-20. Badri M, Wood R. Usefulness of total lym-phocyte count in moritoring highly active antiretroviral therapy in resource-limited settings. A/IDS, 2003, 17:541-5. Jacobson MA et al. Absolute or total lym-phocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretro-viral therapy. A/IDS, 2003, 17(6):917-9. Lorenzi P. Impact of drug resistance mu-tations on virologic response to salvage therapy. AIDS, 1999, 13:17-21. Piketty C et al. Phenotypic resistance to protease inhibitors in patients who HAART predicts the outcome at weeks
- Issued
- 1998
- Type
- article-journal
- As printed
- Chêne G et al. Change in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. A/IDS, 1998, 12(17):2313-20. Badri M, Wood R. Usefulness of total lym-phocyte count in moritoring highly active antiretroviral therapy in resource-limited settings. A/IDS, 2003, 17:541-5. Jacobson MA et al. Absolute or total lym-phocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretro-viral therapy. A/IDS, 2003, 17(6):917-9. Lorenzi P. Impact of drug resistance mu-tations on virologic response to salvage therapy. AIDS, 1999, 13:17-21. Piketty C et al. Phenotypic resistance to protease inhibitors in patients who HAART predicts the outcome at weeks
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.19 - provenance: extracted
- read from
references/10665-117378.page-011.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md
-
twelve of five-drug combination including ritonavir, saquinavir and efavirenz. AIDS, 2000, 14:626-8. Boden D et al. HIV1 resistance in newly in-fected individuals. Journal ofthe American Medical Association, 1999, 282:1135-41. Havlir D et al. Drug susceptibility in HIV infection after rebound in patients recei-ving indinavir containing regimen. Journal of the American Medical Association, 2000, 283:229-34. Akakpo J. Effets indésirables des thé-rapies antirétrovirales chez les patients traités à Cotonou [Thèse de médecine]. Cotonou, 2004, N° 1087 : 87. Carr À, Cooper DA. Adverse effects of antiretroviral therapy. Lancet, 2000, 356:1423-30.
· extracted · source:references/10665-117378.page-011.23.jsontwelve of five-drug combination including ritonavir, saquinavir and efavirenz. AIDS, 2000, 14:626-8. Boden D et al. HIV1 resistance in newly in-fected individuals. Journal ofthe American Medical Association, 1999, 282:1135-41. Havlir D et al. Drug susceptibility in HIV infection after rebound in patients recei-ving indinavir containing regimen. Journal of the American Medical Association, 2000, 283:229-34. Akakpo J. Effets indésirables des thé-rapies antirétrovirales chez les patients traités à Cotonou [Thèse de médecine]. Cotonou, 2004, N° 1087 : 87. Carr À, Cooper DA. Adverse effects of antiretroviral therapy. Lancet, 2000, 356:1423-30.
- Issued
- 2000
- Type
- article-journal
- As printed
- twelve of five-drug combination including ritonavir, saquinavir and efavirenz. AIDS, 2000, 14:626-8. Boden D et al. HIV1 resistance in newly in-fected individuals. Journal ofthe American Medical Association, 1999, 282:1135-41. Havlir D et al. Drug susceptibility in HIV infection after rebound in patients recei-ving indinavir containing regimen. Journal of the American Medical Association, 2000, 283:229-34. Akakpo J. Effets indésirables des thé-rapies antirétrovirales chez les patients traités à Cotonou [Thèse de médecine]. Cotonou, 2004, N° 1087 : 87. Carr À, Cooper DA. Adverse effects of antiretroviral therapy. Lancet, 2000, 356:1423-30.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-117378.page-011.23 - provenance: extracted
- read from
references/10665-117378.page-011.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-117378/sections/page-011.md